Literature DB >> 24664510

Borrelia burgdorferi RNA induces type I and III interferons via Toll-like receptor 7 and contributes to production of NF-κB-dependent cytokines.

Andrea C Love1, Ira Schwartz, Mary M Petzke.   

Abstract

Borrelia burgdorferi elicits a potent cytokine response through activation of multiple signaling receptors on innate immune cells. Spirochetal lipoproteins initiate expression of NF-κB-dependent cytokines primarily via TLR2, whereas type I interferon (IFN) production is induced through the endosomal receptors TLR7 and TLR9 in human dendritic cells and TLR8 in monocytes. We demonstrate that DNA and RNA are the B. burgdorferi components that initiate a type I IFN response by human peripheral blood mononuclear cells (PBMCs). IFN-α protein and transcripts for IRF7, MX1, and OAS1 were induced by endosomal delivery of B. burgdorferi DNA, RNA, or whole-cell lysate, but not by lysate that had been treated with DNase and RNase. Induction of IFN-α and IFN-λ1, a type III IFN, by B. burgdorferi RNA or live spirochetes required TLR7-dependent signaling and correlated with significantly enhanced transcription and expression of IRF7 but not IRF3. Induction of type I and type III IFNs by B. burgdorferi RNA could be completely abrogated by a TLR7 inhibitor, IRS661. In addition to type I and type III IFNs, B. burgdorferi RNA contributed to the production of the NF-κB-dependent cytokines, IFN-γ, interleukin-10 (IL-10), IL-1β, IL-6, and tumor necrosis factor alpha (TNF-α), by human PBMCs. Collectively, these data indicate that TLR7-dependent recognition of RNA is pivotal for IFN-α and IFN-λ1 production by human PBMCs, and that RNA-initiated signaling contributes to full potentiation of the cytokine response generated during B. burgdorferi infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24664510      PMCID: PMC4019181          DOI: 10.1128/IAI.01617-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  90 in total

1.  Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria.

Authors:  Giuseppe Mancuso; Angelina Midiri; Carmelo Biondo; Concetta Beninati; Sebastiana Zummo; Roberta Galbo; Francesco Tomasello; Maria Gambuzza; Giancarlo Macrì; Alessia Ruggeri; Tomas Leanderson; Giuseppe Teti
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

Review 2.  IRF7: activation, regulation, modification and function.

Authors:  S Ning; J S Pagano; G N Barber
Journal:  Genes Immun       Date:  2011-04-14       Impact factor: 2.676

3.  MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists.

Authors:  Aranya Bagchi; Elizabeth A Herrup; H Shaw Warren; James Trigilio; Hae-Sook Shin; Catherine Valentine; Judith Hellman
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

4.  Inhibition of dynamin-dependent endocytosis interferes with type III IFN expression in bacteria-infected human monocyte-derived DCs.

Authors:  Taija E Pietilä; Sinikka Latvala; Pamela Osterlund; Ilkka Julkunen
Journal:  J Leukoc Biol       Date:  2010-07-07       Impact factor: 4.962

5.  Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta.

Authors:  Jorge L Cervantes; Star M Dunham-Ems; Carson J La Vake; Mary M Petzke; Bikash Sahay; Timothy J Sellati; Justin D Radolf; Juan C Salazar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

6.  Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection.

Authors:  Nina Gratz; Harald Hartweger; Ulrich Matt; Franz Kratochvill; Marton Janos; Stefanie Sigel; Barbara Drobits; Xiao-Dong Li; Sylvia Knapp; Pavel Kovarik
Journal:  PLoS Pathog       Date:  2011-05-19       Impact factor: 6.823

7.  A bacterial protein targets the BAHD1 chromatin complex to stimulate type III interferon response.

Authors:  Alice Lebreton; Goran Lakisic; Viviana Job; Lauriane Fritsch; To Nam Tham; Ana Camejo; Pierre-Jean Matteï; Béatrice Regnault; Marie-Anne Nahori; Didier Cabanes; Alexis Gautreau; Slimane Ait-Si-Ali; Andréa Dessen; Pascale Cossart; Hélène Bierne
Journal:  Science       Date:  2011-01-20       Impact factor: 47.728

Review 8.  The STING pathway and regulation of innate immune signaling in response to DNA pathogens.

Authors:  Hiroki Ishikawa; Glen N Barber
Journal:  Cell Mol Life Sci       Date:  2010-12-15       Impact factor: 9.261

9.  Human integrin α(3)β(1) regulates TLR2 recognition of lipopeptides from endosomal compartments.

Authors:  Meghan L Marre; Tanja Petnicki-Ocwieja; Alicia S DeFrancesco; Courtney T Darcy; Linden T Hu
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

10.  IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease.

Authors:  Ourania Koltsida; Michael Hausding; Athanasios Stavropoulos; Sonja Koch; George Tzelepis; Caroline Ubel; Sergei V Kotenko; Paschalis Sideras; Hans A Lehr; Marcus Tepe; Kevin M Klucher; Sean E Doyle; Markus F Neurath; Susetta Finotto; Evangelos Andreakos
Journal:  EMBO Mol Med       Date:  2011-05-03       Impact factor: 12.137

View more
  31 in total

1.  Functional Immune Cell Differences Associated With Low Vaccine Responses in Infants.

Authors:  Michael E Pichichero; Janet R Casey; Anthony Almudevar; Saleem Basha; Naveen Surendran; Ravinder Kaur; Matthew Morris; Alexandra M Livingstone; Tim R Mosmann
Journal:  J Infect Dis       Date:  2016-02-09       Impact factor: 5.226

Review 2.  Type III IFNs: Beyond antiviral protection.

Authors:  Sergei V Kotenko; Amariliz Rivera; Dane Parker; Joan E Durbin
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

3.  Infants with low vaccine antibody responses have altered innate cytokine response.

Authors:  Naveen Surendran; Ted Nicolosi; Michael Pichichero
Journal:  Vaccine       Date:  2016-10-13       Impact factor: 3.641

4.  MicroRNA-541 promotes the proliferation of vascular smooth muscle cells by targeting IRF7.

Authors:  Fang Yang; Zonglei Xu; Shaobin Duan; Min Luo
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

5.  Transcriptome Assessment of Erythema Migrans Skin Lesions in Patients With Early Lyme Disease Reveals Predominant Interferon Signaling.

Authors:  Adriana Marques; Ira Schwartz; Gary P Wormser; Yanmei Wang; Ronald L Hornung; Cumhur Y Demirkale; Peter J Munson; Siu-Ping Turk; Carla Williams; Chyi-Chia Richard Lee; Jun Yang; Mary M Petzke
Journal:  J Infect Dis       Date:  2017-12-27       Impact factor: 5.226

6.  Induction of indoleamine 2,3-dioxygenase by Borrelia burgdorferi in human immune cells correlates with pathogenic potential.

Authors:  Andrea C Love; Ira Schwartz; Mary M Petzke
Journal:  J Leukoc Biol       Date:  2014-11-24       Impact factor: 4.962

7.  Borrelia burgdorferi arthritis-associated locus Bbaa1 regulates Lyme arthritis and K/B×N serum transfer arthritis through intrinsic control of type I IFN production.

Authors:  Ying Ma; Kenneth K C Bramwell; Robert B Lochhead; Jackie K Paquette; James F Zachary; John H Weis; Cory Teuscher; Janis J Weis
Journal:  J Immunol       Date:  2014-11-05       Impact factor: 5.422

Review 8.  The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability.

Authors:  Gerwyn Morris; Michael Berk; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

9.  Genetic Control of Lyme Arthritis by Borrelia burgdorferi Arthritis-Associated Locus 1 Is Dependent on Localized Differential Production of IFN-β and Requires Upregulation of Myostatin.

Authors:  Jackie K Paquette; Ying Ma; Colleen Fisher; Jinze Li; Sang Beum Lee; James F Zachary; Yong Soo Kim; Cory Teuscher; Janis J Weis
Journal:  J Immunol       Date:  2017-10-06       Impact factor: 5.422

10.  RNA of Enterococcus faecalis Strain EC-12 Is a Major Component Inducing Interleukin-12 Production from Human Monocytic Cells.

Authors:  Ryoichiro Nishibayashi; Ryo Inoue; Yuri Harada; Takumi Watanabe; Yuko Makioka; Kazunari Ushida
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.